Article
Clinical severity and cardiac phenotype in phosphomannomutase 2-congenital disorders of glycosylation : Insights into genetics and management recommendations.
Journal of inherited metabolic disease - 1 Jan 2025
Holubova Veronika, Barone Rita, Grunewald Stephanie, Tesařová Markéta, Hansíková Hana, Augustínová Jana, Sykut-Cegielska Jolanta, De Nictolis Francesca, Diaz-Moreno Unai, Elangovan Ramyia, Epifani Florencia, Gasperini Serena, Jansen Mirian, Lefeber Dirk, Maksym-Gasiorek Dorota, Diego Martinelli, Ounap Katrin, Pettinato Fabio, Põder Haide, Rymen Daisy, Vals Mari-Anne, Serrano Mercedes, Witters Peter, Honzík Tomáš
Abstract excerpt
Cardiac involvement (CI) in phosphomannomutase 2-congenital disorders of glycosylation (PMM2-CDG) is part of the multisystemic presentation contributing to high mortality rates. The most common cardiac manifestations are pericardial effusion, cardiomyopathy, and structural heart defects. A genotype-phenotype correlation with organ involvement has not yet been described. We analyzed clinical, biochemical, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
